Free Trial

Soleno Therapeutics (SLNO) Competitors

Soleno Therapeutics logo
$86.08 +3.45 (+4.18%)
As of 03:41 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SLNO vs. SNN, SOLV, PEN, STVN, GKOS, IRTC, NARI, TMDX, BLCO, and INSP

Should you be buying Soleno Therapeutics stock or one of its competitors? The main competitors of Soleno Therapeutics include Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

Soleno Therapeutics vs. Its Competitors

Soleno Therapeutics (NASDAQ:SLNO) and Smith & Nephew SNATS (NYSE:SNN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

97.4% of Soleno Therapeutics shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 6.4% of Soleno Therapeutics shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Smith & Nephew SNATS has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Smith & Nephew SNATS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Soleno TherapeuticsN/AN/A-$175.85M-$4.62-18.63
Smith & Nephew SNATS$5.81B2.27$412M$2.1613.95

Smith & Nephew SNATS's return on equity of 0.00% beat Soleno Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Soleno TherapeuticsN/A -77.52% -63.44%
Smith & Nephew SNATS N/A N/A N/A

Soleno Therapeutics presently has a consensus price target of $107.10, indicating a potential upside of 24.42%. Smith & Nephew SNATS has a consensus price target of $28.00, indicating a potential downside of 7.05%. Given Soleno Therapeutics' stronger consensus rating and higher possible upside, equities analysts plainly believe Soleno Therapeutics is more favorable than Smith & Nephew SNATS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Soleno Therapeutics
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
3.09
Smith & Nephew SNATS
0 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Soleno Therapeutics has a beta of -2.63, suggesting that its share price is 363% less volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500.

In the previous week, Soleno Therapeutics had 5 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 6 mentions for Soleno Therapeutics and 1 mentions for Smith & Nephew SNATS. Smith & Nephew SNATS's average media sentiment score of 1.22 beat Soleno Therapeutics' score of 0.77 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Soleno Therapeutics
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Smith & Nephew SNATS
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Smith & Nephew SNATS beats Soleno Therapeutics on 8 of the 15 factors compared between the two stocks.

Get Soleno Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLNO vs. The Competition

MetricSoleno TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$4.34B$2.42B$5.50B$8.93B
Dividend YieldN/A1.79%5.38%4.12%
P/E Ratio-18.668.9426.2519.86
Price / SalesN/A665.31415.14113.78
Price / CashN/A154.3736.4957.06
Price / Book15.164.548.055.38
Net Income-$175.85M$31.16M$3.16B$248.50M
7 Day Performance0.34%0.15%1.78%2.78%
1 Month Performance13.77%8.74%4.74%5.84%
1 Year Performance116.66%2.17%35.81%20.06%

Soleno Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLNO
Soleno Therapeutics
4.6793 of 5 stars
$86.08
+4.2%
$107.10
+24.4%
+95.4%$4.34BN/A-18.6630
SNN
Smith & Nephew SNATS
3.604 of 5 stars
$29.17
+1.2%
$28.00
-4.0%
+24.8%$12.77B$5.81B13.5017,349Positive News
SOLV
Solventum
0.8839 of 5 stars
$73.21
-0.5%
$80.29
+9.7%
+51.4%$12.67B$8.31B33.8922,000Positive News
Analyst Upgrade
PEN
Penumbra
4.7309 of 5 stars
$254.41
-1.0%
$302.40
+18.9%
+41.8%$9.85B$1.19B240.014,500Positive News
STVN
Stevanato Group
N/A€23.62
+1.4%
N/A+32.9%€7.15B€1.19B46.315,521Positive News
Analyst Forecast
Gap Down
GKOS
Glaukos
4.4219 of 5 stars
$96.80
-3.3%
$134.67
+39.1%
-12.6%$5.53B$383.48M-40.84780
IRTC
iRhythm Technologies
1.2242 of 5 stars
$150.95
+3.6%
$138.60
-8.2%
+37.1%$4.82B$591.84M-48.072,000Positive News
NARI
Inari Medical
0.4704 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.5784 of 5 stars
$127.53
+3.2%
$127.33
-0.2%
-13.4%$4.31B$441.54M93.77210Positive News
BLCO
Bausch + Lomb
3.3387 of 5 stars
$12.01
+2.3%
$15.54
+29.5%
-7.7%$4.25B$4.79B-11.6613,500
INSP
Inspire Medical Systems
4.8319 of 5 stars
$129.88
-0.8%
$211.91
+63.2%
-5.8%$3.83B$840.11M59.851,246

Related Companies and Tools


This page (NASDAQ:SLNO) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners